Literature DB >> 1384353

Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis.

W B Weglicki1, T M Phillips.   

Abstract

During the progression of Mg deficiency in a rodent model, we have observed dramatic increases in serum levels of inflammatory cytokines [interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha)] after 3 wk on a Mg-deficient diet. Sequential analyses of these cytokine changes in the serum of rats revealed an initial rise at day 12, followed by a major elevation in all three cytokine levels by day 21. Of greater interest was an early peak in the serum level of the neuropeptide substance P after only 5 days on the diet. This "neuronal" tachykinin is thought to be released from neural tissues, and it is known to stimulate production of certain cytokines, including IL-1, IL-6, and TNF-alpha. In addition, there was a concomitant increase in histamine levels, which may have resulted from stimulation and degranulation of mast cells by substance P. Thus we hypothesize that the release of substance P may be the earliest pathophysiological event leading to stimulation of the inflammatory cytokines, which may then stimulate the free radical mechanisms of injury previously confirmed by our work.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384353     DOI: 10.1152/ajpregu.1992.263.3.R734

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

1.  The role of magnesium deficiency in cardiovascular and intestinal inflammation.

Authors:  William B Weglicki; Iu Tong Mak; Joanna J Chmielinska; Maria Isabel Tejero-Taldo; Andrei M Komarov; Jay H Kramer
Journal:  Magnes Res       Date:  2010-10-25       Impact factor: 1.115

Review 2.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

Review 3.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

Review 4.  The role of neuropeptides in adverse myocardial remodeling and heart failure.

Authors:  Alexander Widiapradja; Prasad Chunduri; Scott P Levick
Journal:  Cell Mol Life Sci       Date:  2017-01-17       Impact factor: 9.261

5.  EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.

Authors:  I Tong Mak; Jay H Kramer; Joanna J Chmielinska; Christopher F Spurney; William B Weglicki
Journal:  J Cardiovasc Pharmacol       Date:  2015-01       Impact factor: 3.105

6.  Brain protection by rapeseed oil in magnesium-deficient mice.

Authors:  Nicole Pages; Pierre Maurois; Bernadette Delplanque; Pierre Bac; Jean-Charles Martin; Qin Du; Stanley I Rapoport; Joseph Vamecq
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-06-12       Impact factor: 4.006

Review 7.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

8.  Serum magnesium and stable asthma: Is there a link?

Authors:  Sibes Kumar Das; Arup Kumar Haldar; Indranath Ghosh; Samirendra Kumar Saha; Anirban Das; Saurabh Biswas
Journal:  Lung India       Date:  2010-10

9.  Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency.

Authors:  W B Weglicki; R E Stafford; B F Dickens; I T Mak; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

10.  Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia.

Authors:  William B Weglicki; Joanna J Chmielinska; Isabel Tejero-Taldo; Jay H Kramer; Christopher F Spurney; Kandan Viswalingham; Bao Lu; I Tong Mak
Journal:  Magnes Res       Date:  2009-09       Impact factor: 1.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.